VOYA Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-83,029
| Closed | -$340K | – | 2969 |
|
|
2022
Q1 | $340K | Sell |
83,029
-599
| -0.7% | -$2.17K | ﹤0.01% | 2119 |
|
|
2021
Q4 | $299K | Sell |
83,628
-20,669
| -20% | -$72.3K | ﹤0.01% | 2306 |
|
|
2021
Q3 | $380K | Sell |
104,297
-14,916
| -13% | -$60.3K | ﹤0.01% | 2213 |
|
|
2021
Q2 | $520K | Buy |
119,213
+9,440
| +9% | +$38.5K | ﹤0.01% | 2060 |
|
|
2021
Q1 | $451K | Buy |
109,773
+16,863
| +18% | +$73.1K | ﹤0.01% | 2094 |
|
|
2020
Q4 | $370K | Buy |
92,910
+33,731
| +57% | +$109K | ﹤0.01% | 2091 |
|
|
2020
Q3 | $160K | Hold |
59,179
| – | – | ﹤0.01% | 2227 |
|
|
2020
Q2 | $163K | Sell |
59,179
-25,219
| -30% | -$70.4K | ﹤0.01% | 2224 |
|
|
2020
Q1 | $199K | Buy |
84,398
+5,998
| +8% | +$20.4K | ﹤0.01% | 2130 |
|
|
2019
Q4 | $368K | Buy |
78,400
+14,712
| +23% | +$60.2K | ﹤0.01% | 2065 |
|
|
2019
Q3 | $213K | Hold |
63,688
| – | – | ﹤0.01% | 2222 |
|
|
2019
Q2 | $210K | Buy |
63,688
+1,070
| +2% | +$3.1K | ﹤0.01% | 2279 |
|
|
2019
Q1 | $190K | Hold |
62,618
| – | – | ﹤0.01% | 2283 |
|
|
2018
Q4 | $170K | Buy |
62,618
+4,815
| +8% | +$15.9K | ﹤0.01% | 2271 |
|
|
2018
Q3 | $194K | Hold |
57,803
| – | – | ﹤0.01% | 2343 |
|
|
2018
Q2 | $149K | Sell |
57,803
-7,270
| -11% | -$18.1K | ﹤0.01% | 2442 |
|
|
2018
Q1 | $143K | Hold |
65,073
| – | – | ﹤0.01% | 2412 |
|
|
2017
Q4 | $129K | Hold |
65,073
| – | – | ﹤0.01% | 2455 |
|
|
2017
Q3 | $211K | Hold |
65,073
| – | – | ﹤0.01% | 2360 |
|
|
2017
Q2 | $210K | Buy |
+65,073
| New | +$184K | ﹤0.01% | 2388 |
|
|
2016
Q2 | – | Sell |
-93,600
| Closed | -$81K | – | 2597 |
|
|
2016
Q1 | $81K | Hold |
93,600
| – | – | ﹤0.01% | 2433 |
|
|
2015
Q4 | $113K | Hold |
93,600
| – | – | ﹤0.01% | 2457 |
|
|
2015
Q3 | $159K | Hold |
93,600
| – | – | ﹤0.01% | 2360 |
|
|
2015
Q2 | $195K | Hold |
93,600
| – | – | ﹤0.01% | 2492 |
|
|
2015
Q1 | $254K | Hold |
93,600
| – | – | ﹤0.01% | 2336 |
|
|
2014
Q4 | $241K | Hold |
93,600
| – | – | ﹤0.01% | 2387 |
|
|
2014
Q3 | $171K | Hold |
93,600
| – | – | ﹤0.01% | 2534 |
|
|
2014
Q2 | $250K | Hold |
93,600
| – | – | ﹤0.01% | 2446 |
|
|
2014
Q1 | $328K | Hold |
93,600
| – | – | ﹤0.01% | 2271 |
|
|
2013
Q4 | $419K | Hold |
93,600
| – | – | ﹤0.01% | 2094 |
|
|
2013
Q3 | $380K | Hold |
93,600
| – | – | ﹤0.01% | 2120 |
|
|
2013
Q2 | $389K | Buy |
+93,600
| New | +$362K | ﹤0.01% | 2038 |
|
Other funds holding ATRS
VOYA Investment Management's ATRS Position: Q2 2022 in Review
VOYA Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 83,029 shares — an estimated $340K sold.
VOYA Investment Management first reported a position in ATRS in Q2 2013 and held it in 32 quarters. The position peaked at $520K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- VOYA Investment Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- VOYA Investment Management sold 83,029 Antares Pharma, Inc. shares in Q2 2022, an estimated $340K.
- VOYA Investment Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 32 quarters.
- VOYA Investment Management's Antares Pharma, Inc. position peaked at $520K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.